Biote schedules fourth quarter and full year 2022 financial results release and conference call

Irving, texas--(business wire)--biote corp. (nasdaq: btmd) (“biote” or the “company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announced the company will provide fourth quarter and full year financial results on tuesday, march 28, 2023, after the close of the market. a conference call to discuss the firm's results will be held wednesday, march 29, 2023 at 8:30 a.m. et.
BTMD Ratings Summary
BTMD Quant Ranking